文献速递肾癌与肾肿瘤

T1a期肾细胞癌所选治疗方式的演变趋势

Evolving Trends for Selected Treatments of T1a Renal Cell Carcinoma.
PubMed 文献 · Urology · 2019-07-04

基于美国国家癌症数据库2002至2015年数据,共纳入75,691例T1a期肾肿瘤患者,评估小肾肿瘤治疗趋势及年龄对治疗选择的影响。结果显示部分肾切除术占52%、根治性肾切除术占28%、消融占12%、主动监测占8%;过去十年部分肾切除术、消融和监测相对根治性肾切除术的使用可能性持续增加,年龄增长与部分肾切除术可能性降低及消融或主动监测可能性升高独立相关。

要点

  • T1a期肾肿瘤中部分肾切除术占52%,已取代根治性肾切除术成为主要手术方式。
  • 过去十年部分肾切除术、消融和监测相对根治性肾切除术的使用可能性持续增加。
  • 年龄增长与部分肾切除术可能性降低及消融或主动监测可能性升高独立相关。

核心结论

  • 小肾肿瘤治疗趋势持续演变,过去十年部分肾切除术取代根治性肾切除术成为主要手术治疗方式。
  • 年龄显著影响治疗选择,老年队列更可能接受消融或主动监测。
  • 尽管微创治疗使用增加,主动监测的使用仍落后于支持其使用的质量数据。
  • 控制多种临床因素后,部分肾切除术、消融和监测相对根治性肾切除术的使用持续增加。

研究设计与样本

  • 使用美国国家癌症数据库参与者用户文件(2002至2015年)识别T1a期肾肿瘤患者,共75,691例。
  • 初始治疗分为根治性肾切除术、部分肾切除术、消融或主动监测。
  • 采用多项逻辑回归模型识别影响治疗的显著因素。

主要发现

  • 根治性肾切除术、部分肾切除术和消融分别占28%、52%和12%,8%接受主动监测。
  • 过去十年部分肾切除术、消融或监测相对根治性肾切除术的可能性持续增加,独立于年龄、性别、种族、合并症、肿瘤大小或机构。
  • 与40岁以下患者相比,70至79岁患者接受部分肾切除术的可能性远低(RR 0.58,P< .01),接受消融(RR 5.53,P< .01)或主动监测(RR 3.7,P< .01)的可能性远高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate contemporary trends in the management of small renal masses and how patient age has impacted practice patterns. METHODS: Using the NCDB Participant User File (PUF) from 2002 to 2015, we identified patients with T1a renal masses. The initial treatment was categorized as radical nephrectomy (RN), partial nephrectomy (PN), ablation, or active surveillance (AS). A multinominal logistic regression model was used to identify significant factors impacting treatment. RESULTS: We identified 75,691 patients for analysis. RN, PN, and ablation accounted for 28%, 52%, and 12%, respectively, while 8% were managed with AS. In the past decade the likelihood of undergoing PN, ablation, or surveillance compared to RN has consistently increased, independent of age, sex, race, comorbidity, tumor size, or institution. As age increased, patients were independently less likely to undergo PN and more likely to be managed with ablation or AS. Compared to patients under 40 years of age, patients between 70 and 79 were far less likely to undergo PN (RR 0.58, P< .01), and far more likely to undergo either ablation (RR 5.53, P< .01) or AS (RR 3.7, P< .01). CONCLUSION: Trends in small renal mass management continue to evolve, with PN supplanting RN over the past decade as the predominant surgical treatment. Age significantly impacts treatment selection, particularly in older cohorts whom are much more likely to undergo ablation or AS. While the use of minimally invasive therapies has increased over the past decade, AS lags behind despite quality data supporting its use. When controlling for multiple clinical factors, PN, ablation and surveillance have consistently increased in utilization compared to RN.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Doolittle J, Piotrowski J, Zuk K, et al. Evolving Trends for Selected Treatments of T1a Renal Cell Carcinoma. Urology. 2019. PMID: 31279691. doi:10.1016/j.urology.2019.06.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。